医学
糖尿病性视网膜病变
致盲
视网膜病变
疾病
糖尿病管理
糖尿病
疾病管理
慢性病
重症监护医学
阶段(地层学)
2型糖尿病
内科学
临床试验
古生物学
帕金森病
生物
内分泌学
作者
Yun‐Hwei Shen,Yanhui Ma,Y F Wang,Kai Liu,Xun Xu
出处
期刊:PubMed
日期:2022-12-06
卷期号:56 (12): 1889-1892
标识
DOI:10.3760/cma.j.cn112150-20220222-00164
摘要
Diabetic retinopathy (DR), one of the chronic complications of diabetes, is a serious and irreversible blinding disease. It is difficult to detect in the early stage, to control in the progressive stage, to operate in the advanced stage of DR. Recently, the "14th Five-year plan" for National Eye Health proposed to "improve the management mode of chronic eye disease, and build a chronic disease management system". The project team used artificial intelligence technology based on cloud platform, joint outpatient service, virtual ward to explore the comprehensive management of DR from the aspects of early screening, multidisciplinary collaborative diagnosis and treatment, and refined blood glucose management during perioperative period. In the future, it is urgent to integrate DR chronic disease management with other systemic chronic diseases to reduce the blindness caused by DR.糖尿病性视网膜病变(diabetic retinopathy,DR)是糖尿病慢性并发症之一,是严重的、难逆转的致盲性眼病,早期难发现、中期难控制、晚期难手术。近期“十四五”全国眼健康规划提出了“完善慢性眼病患者管理模式,构建眼病慢病管理体系”。本项目团队前期运用基于云平台的人工智能技术、联合门诊、云端虚拟病房等方式从早期筛查、进展期多学科协作诊疗、晚期围手术期血糖精细化管理等方面探索DR全病程慢病综合管理。未来亟待将DR慢病管理与全身系统性疾病综合管理融合链接,减少DR导致的盲。.
科研通智能强力驱动
Strongly Powered by AbleSci AI